SenseUP’s platform tech could overcome the cost and stability hurdles holding back RNAi-based crop protection, claims the ...
Nathaniel Clark, PhD, is a senior scientist at Repligen. He has a doctorate in biochemistry and structural biology from UMass Amherst and studied RNA as a postdoctoral researcher at the University of ...
OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIMI) (NYSE American: AIM) (OTC Pink: AIMID) (“AIM” or the “Company”) today announced the United States Patent and Trademark Office ...
Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines. RNA-based medicines are one of the most promising ways to fight human disease, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback